Former Senior Vice President, Chief Enterprise Transformation Officer · Chemours Co (CC)

Matthew Abbott

FY2024 is the first fiscal year CompBrief holds for Matthew Abbott as a named executive officer of Chemours; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,996,873

Salary $589,167Stock awards $712,271

2nd of 8 named executive officers at Chemours by FY2024 total.

8 named officers on file for Chemours, FY2024

Matthew Abbott’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 4 equity grants, each cited to its filing
  • CC’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Chemours’s whole pay program stands against its peers

  • Chemours’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 20, 2025 (DEF 14A).

Free

Get Matthew Abbott’s full pay file as a PDF — free

More than this page: up to 10 years of Matthew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Matthew Abbott compensation by year

Chemours Summary Compensation Table · the one fiscal year held
In US dollars, as Chemours reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$589,167
Stock awards$712,271
Option awards$655,426
Non-equity incentive$0
Pension and deferred compensation$0
All other$40,009
Total$1,996,873

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Chemours Co DEF 14A filed March 20, 2025, accession 0001104659-25-025816, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Chemours Co filed document, accession 0001104659-25-025816. Every figure is read from that document and cited to the page and table it appears in. Filed March 20, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU12,267$207,309—
RSU12,105$204,582—
RSU2,849$48,150—
RSU1,549$26,185—
PSU1,173$19,823—
RSU446$7,546—
Option3,395—$38.32
Option3,309—$34.84
Option4,247—$25.98
Option32,879—$30.25
Option31,614—$27.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Chemours Co's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Chemours’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Denise DignamPresident and Chief Executive Officer$5,887,980
Matthew Abbott · this pageFormer Senior Vice President, Chief Enterprise Transformation Officer$1,996,873
Kristine WellmanSenior Vice President, General Counsel and Corporate Secretary$1,820,645
Joseph MartinkoPresident, Thermal & Specialized Solutions$1,433,046
Gerardo FamiliarPresident, Advanced Performance Materials$1,373,997
Shane HostetterSenior Vice President, Chief Financial Officer$1,049,865
Mark NewmanFormer President and Chief Executive Officer$297,851
Jonathan LockFormer Senior Vice President, Chief Financial Officer$225,728

The full Chemours compensation record

free company brief

This page is one person within Chemours's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Chemours proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Chemours's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Matthew Abbott's compensation dossier · One-time report. No refunds.